Source link : https://www.newshealth.biz/health-news/is-one-cycle-of-neoadjuvant-pembro-ok-in-dmmr-colon-cancer/
For most patients with clinical stage I-II deficient mismatch repair (dMMR) colon cancer, a single cycle of neoadjuvant pembrolizumab may be sufficient to achieve a pathologic complete response, according to the final analysis of the RESET-C study. After one cycle of neoadjuvant pembrolizumab, 61% and 33% of patients with clinical stage I-II and stage III […]
Author : News Health
Publish date : 2025-01-30 13:35:38
Copyright for syndicated content belongs to the linked Source.